Additionally, a previous study has demonstrated that CTNNB1 mutation subgroup was significantly associated with a better prognosis and a higher TMB compared with the wild-type subgroup in the TCGA-HCC cohort (19). The gene discussed is CTNNB1; the disease is hepatocellular carcinoma.